SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.
作者信息
Marjot Thomas, Webb Gwilym J, Barritt Alfred S, Ginès Pere, Lohse Ansgar W, Moon Andrew M, Pose Elisa, Trivedi Palak, Barnes Eleanor
机构信息
Oxford Liver Unit, Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
Cambridge Liver Unit, Cambridge University Hospitals NHS Trust, Addenbrookes Hospital, Cambridge, UK.
出版信息
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158. doi: 10.1016/S2468-1253(21)00008-X. Epub 2021 Jan 11.
Abstract
摘要
相似文献
1
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.肝病患者的新冠病毒疫苗接种：应对下一个重大问题。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158. doi: 10.1016/S2468-1253(21)00008-X. Epub 2021 Jan 11.
2
What Are COVID-19 Vaccines?什么是新冠疫苗？
Am J Respir Crit Care Med. 2021 May 1;203(9):P22-P23. doi: 10.1164/rccm.2021C2.
3
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.儿童炎症性肠病患者感染或接种SARS-CoV-2后的血清转化
Inflamm Bowel Dis. 2021 Oct 20;27(11):1862-1864. doi: 10.1093/ibd/izab194.
4
Why Oxford's positive COVID vaccine results are puzzling scientists.为何牛津大学新冠疫苗的阳性结果令科学家们感到困惑。
Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.
5
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.风湿科医师新加坡分会关于风湿性疾病患者接种 COVID-19 疫苗的建议。
Int J Rheum Dis. 2021 Jun;24(6):746-757. doi: 10.1111/1756-185X.14107. Epub 2021 May 10.
6
Covid-19 vaccines and new mutant strains impacting the pandemic.新冠疫苗与影响疫情的新突变株。
Indian J Tuberc. 2021 Apr;68(2):171-173. doi: 10.1016/j.ijtb.2021.03.010.
7
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.用于开发 SARS-CoV-2 候选疫苗的新型疫苗生产平台。
Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24.
8
[Allergic reactions to COVID-19 vaccines].[对新冠病毒疫苗的过敏反应]
Ned Tijdschr Geneeskd. 2021 Feb 5;165:D5804.
9
[Immunity against SARS-CoV-2: walking to the vaccination].[对严重急性呼吸综合征冠状病毒2的免疫：迈向疫苗接种之路]
Rev Esp Quimioter. 2020 Dec;33(6):392-398. doi: 10.37201/req/086.2020. Epub 2020 Sep 11.
10
Covid-19 vaccines: delivering protective immunity.新冠疫苗：提供保护性免疫
BMJ. 2020 Dec 17;371:m4838. doi: 10.1136/bmj.m4838.
引用本文的文献
1
Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic.2019冠状病毒病疫苗接种对住院率和死亡率的影响：大流行早期临床结局的比较分析
Infect Dis Rep. 2025 Jun 27;17(4):74. doi: 10.3390/idr17040074.
2
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups.新型冠状病毒肺炎相关肝损伤：风险群体机制与管理的最新综述
Liver Res. 2023 Jul 13;7(3):207-215. doi: 10.1016/j.livres.2023.07.001. eCollection 2023 Sep.
3
COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.肝硬化患者的 COVID-19 疫苗接种：安全性、免疫及临床反应
GE Port J Gastroenterol. 2023 Nov 15;31(5):325-337. doi: 10.1159/000534740. eCollection 2024 Oct.
4
"Strategies of liver transplantation during the second wave - based on lessons learnt from the first wave of the SARS- COV2 pandemic".第二波疫情期间的肝移植策略——基于第一波新冠疫情的经验教训
J Liver Transpl. 2021 Apr-Jun;2:100015. doi: 10.1016/j.liver.2021.100015. Epub 2021 May 27.
5
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis.新冠病毒疫苗在肝硬化患者中的免疫原性：一项荟萃分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2326316. doi: 10.1080/21645515.2024.2326316. Epub 2024 Mar 11.
6
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.COVID-19 疫苗接种后肝病患者和肝移植受者的免疫反应和临床结局。
J Hepatol. 2024 Jan;80(1):109-123. doi: 10.1016/j.jhep.2023.10.009. Epub 2023 Oct 19.
7
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study.肝硬化患者接种新冠病毒mRNA疫苗后的体液免疫反应：一项前瞻性真实世界单中心研究
Biomedicines. 2023 Apr 28;11(5):1320. doi: 10.3390/biomedicines11051320.
8
Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients.COVID-19疫苗接种在肝硬化患者中的真实世界有效性：一项对51,834例患者进行的系统评价与荟萃分析
Proc (Bayl Univ Med Cent). 2023 Jan 17;36(2):151-156. doi: 10.1080/08998280.2023.2165344. eCollection 2023.
9
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.肝硬化与慢性肝病患者对新冠疫苗的血清学反应较低有关。
JHEP Rep. 2023 May;5(5):100697. doi: 10.1016/j.jhepr.2023.100697. Epub 2023 Feb 20.
10
Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study.严重的 COVID-19 可能通过途径和群体遗传学研究影响肝纤维化/肝星状细胞激活。
Genes (Basel). 2022 Dec 22;14(1):22. doi: 10.3390/genes14010022.
Zotero 插件